These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23519830)
1. Trends in the use of antiasthmatic medications in Morocco (1999-2010). Ghanname I; Ahid S; Berrada G; Belaiche A; Hassar M; Cherrah Y Springerplus; 2013 Dec; 2(1):82. PubMed ID: 23519830 [TBL] [Abstract][Full Text] [Related]
2. Factors influencing anti-asthmatic generic drug consumption in Morocco: 1999-2010. Ghanname I; Ahid S; Berrada G; Belaiche A; Hassar M; Cherrah Y Springerplus; 2014; 3():192. PubMed ID: 24790832 [TBL] [Abstract][Full Text] [Related]
3. Trends in antihypertensives use among Moroccan patients. Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1067-73. PubMed ID: 22585420 [TBL] [Abstract][Full Text] [Related]
4. [Generic drugs and the consumption trends of antihypertensives in Morocco]. Berrada El Azizi G; Ahid S; Ghanname I; Belaiche A; Hassar M; Cherrah Y Therapie; 2013; 68(5):303-12. PubMed ID: 24225041 [TBL] [Abstract][Full Text] [Related]
5. [Not Available]. El Azizi GB; Ahid S; Ghannam I; Belaiche A; Hassar M; Cherrah Y Therapie; 2013; 68(5):303-12. PubMed ID: 27393184 [TBL] [Abstract][Full Text] [Related]
6. [Consumption analyze of the antihypertensive drugs in Morocco: period 1991-2005]. Soussi-Tanani D; Alaoui K; Belaiche A; Hassar M; Cherrah Y Therapie; 2008; 63(2):129-33. PubMed ID: 18561887 [TBL] [Abstract][Full Text] [Related]
7. Trends in the consumption and cost of antiepileptics in Morocco between 2008 and 2018. Cherkaoui G; Cheikh A; Razine R; Bnouhanna W; Regragui W; Benomar A; Cherrah Y Rev Epidemiol Sante Publique; 2022 Apr; 70(2):75-81. PubMed ID: 35337700 [TBL] [Abstract][Full Text] [Related]
8. Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study. Brauer R; Alfageh B; Blais JE; Chan EW; Chui CSL; Hayes JF; Man KKC; Lau WCY; Yan VKC; Beykloo MY; Wang Z; Wei L; Wong ICK Lancet Psychiatry; 2021 Dec; 8(12):1071-1082. PubMed ID: 34801129 [TBL] [Abstract][Full Text] [Related]
9. Trends in the utilization of psychotropic medications in China from 2018 to 2021. Zhang X; Hu X; Zhao Y; Lu CY; Nie X; Shi L Front Pharmacol; 2022; 13():967826. PubMed ID: 36160455 [No Abstract] [Full Text] [Related]
10. Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005-2012. Ponizovsky AM; Marom E; Fitoussi I Pharmacoepidemiol Drug Saf; 2014 May; 23(5):534-8. PubMed ID: 24610676 [TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines use in Morocco: A nation wide consumption database study between 2004 and 2017. Qriouet Z; Belaiche A; Qmichou Z; Cherrah Y; Sefrioui H Asian J Psychiatr; 2020 Jan; 47():101852. PubMed ID: 31759283 [TBL] [Abstract][Full Text] [Related]
12. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate. Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017 [TBL] [Abstract][Full Text] [Related]
13. Changes in consumption of opioid analgesics in Israel 2009 to 2016: An update focusing on oxycodone and fentanyl formulations. Ponizovsky AM; Marom E; Weizman A; Schwartzberg E Pharmacoepidemiol Drug Saf; 2018 May; 27(5):535-540. PubMed ID: 29488288 [TBL] [Abstract][Full Text] [Related]
14. Consumption of methylphenidate and atomoxetine in the private healthcare sector in South Africa: a longitudinal study. Munasur-Naidoo AP; Truter I Int J Clin Pharm; 2019 Aug; 41(4):859-863. PubMed ID: 31313002 [TBL] [Abstract][Full Text] [Related]
15. Utilization of benzodiazepines in Chile during 1982-1986. Ruiz I; Offermanns J; Fuentes P; Castillo M Eur J Clin Pharmacol; 1989; 37(2):139-43. PubMed ID: 2571504 [TBL] [Abstract][Full Text] [Related]
16. Differences in the consumption rates and regulatory barriers to the accessibility of strong opioid analgesics in Israel and St. Petersburg. Ponizovsky AM; Pchelintsev MV; Marom E; Zvartau EE Eur J Clin Pharmacol; 2012 Jan; 68(1):89-95. PubMed ID: 21792563 [TBL] [Abstract][Full Text] [Related]
17. Differences in antidiabetic drug utilisation between three different health systems in the same national region. Benítez J; Puerto AM; Díaz JA Eur J Clin Pharmacol; 1992; 42(2):151-4. PubMed ID: 1618245 [TBL] [Abstract][Full Text] [Related]